When a drug comes out [that's broadly prescribed] there are going to start to be a lot of people on it [in a million person cohort] and you might get therefore an early signal of something unexpected that hadn't come through in the clinical trials. And I'm sure [drug companies] would love it if, in fact, FDA, recognizing that, would say, OK, maybe you don't have to do your trial with 30,000 people because we're going to find out shortly after registration because we'll have a lot of people taking the drug and we'll be able to see what happened using PMI.
A lot of people think PMI is the genome project 2. 0. No. This is about all the influences on disease - genetics is in there, but the environment is in there as well, health choices, behaviors, all the factors that are important, otherwise we're not doing what we promised we would do - which is in a holistic way look at how people stay healthy or how do they fall ill.